Coverage dated September 23, 2026 to September 25, 2026
‘Superpotent': Thyroid tablet recall upgraded to highest risk level by FDA
Headline from NBC Chicago
A recent nationwide thyroid medication recall has been upgraded by the Food and Drug Administration to the agency’s highest risk level, with FDA officials warning the “superpotent” drug could “cause serious adverse health consequences or death.” Drug company Vitruvias Therapeutics Inc.
NBC Chicago's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
A recent nationwide thyroid medication recall has been upgraded by the Food and Drug Administration to the agency’s highest risk level, with FDA officials warning the “superpotent” drug could “cause serious adverse health consequences or death.” Drug company Vitruvias Therapeutics Inc.
